Vorinostat Recruiting Phase 0 Trials for Uveal Melanoma Treatment

IndicationsStatusPurposePhase
RecruitingTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT03022565Vorinostat in Patients With Class 2 High Risk Uveal Melanoma